Midgard Science

Halozyme

Boston, MA, United Stateselektrofi.comFrom their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Halozyme’s Elektrofi unit develops formulation technology for biologic therapies, focusing on low-volume, stable, hyper-concentrated subcutaneous delivery. It works with biopharmaceutical partners on protein therapeutics and related drug-product formats.

Services

  • Biologic formulation development

    Develops low-volume, stable, hyper-concentrated biologic formulations for subcutaneous delivery.

  • Subcutaneous delivery enablement

    Supports conversion of biologic therapies from intravenous administration to subcutaneous administration.

  • Asset-specific formulation customization

    Creates molecule- and asset-specific formulations for nearly any protein therapeutic.

  • Delivery-format compatibility support

    Develops formulations compatible with vials, pre-filled syringes, cartridges, and auto-injectors.

  • Formulation technology development

    Develops hyper concentrated microparticle formulations for biologic therapies.

  • Partnered drug development

    Collaborates with biopharmaceutical companies on development programs for biologic therapies.

  • Commercial-scale GMP manufacturing capacity development

    States plans to establish Ph3 and commercial-scale GMP manufacturing capacity.

Turnaround
Done in seconds, not hours

Capabilities

Scale and capacity
  • Up to 500 mg/ml
  • Ph3 and commercial-scale GMP manufacturing capacity
  • Ph3 manufacturing capacity
  • Commercial-scale GMP manufacturing lines

Modalities and species

Modalities
Antibody

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: manufacturing capacity

Industries served

  • Biotech

Details

Based in
Boston, MA, United States
Serves
Global

Public records

Parent company
HALOZYME THERAPEUTICS, INC. · US GLEIF

Similar labs